Catheter-associated urinary tract infections (CAUTIs) are nosocomial infections, causing more than one million cases per year. CAUTIs cause serious health issues; in addition, the cost of replacement of the device constrains the employment of urological devices. Therefore, there is an urgent need to develop novel biomaterials for use in catheters. In this study, poly hydroxyethyl-methacrylate p(HEMA) and drugs-loaded p(HEMA) with ampicillin trihydrate (AMP), levofloxacin (LVX), and drug combinations were prepared using free radical polymerization. The characterization of the dried films included the determination of glass transition temperature (Tg), ultimate tensile strength, elongation percentage, and Young’s modulus. Formulation toxicity, antimicrobial activity, and biofilm-formation ability were tested. Decreases in Tg value, U.T.S., and Young’s modulus, and an increase in elongation percentage were observed in AMP-loaded p(HEMA). Different ratios of drug combinations increased the Tg values. The films exhibited a cell viability higher than 80% on HEK 293 cells. Antimicrobial activity increased when p(HEMA) was loaded with LVX or a combination of LVX and AMP. Biofilm-forming ability reduced after the addition of antimicrobial agents to the films. p(HEMA) impregnated with AMP, LVX, and drug combinations showed significantly increased antimicrobial activity and decreased biofilm-forming ability compared with p(HEMA), in addition to the effects on (HEMA) mechanical properties.
12 January 2026 in Journal of Pharmaceutical Innovation
Purpose Cigarette smoking leads to the cause of mortality. Current smoking cessation often fails to prevent cravings. Intranasal drugs offer a rapid alternative, but existing nasal sprays require frequent dosing, affecting patient adherence. We developed sustained-release nicotine-encapsulated chitosan nanoparticles (NHT-loaded CSNPs) to prolong nicotine effects. Methods NHT CSNPs were synthesized using ionic gelation. Their size and zeta potential were determined. Stability studies were conducted for 90 days. In vitro release kinetics and cytotoxicity were assessed. Pharmacokinetic properties of the NHT-loaded CSNPs were performed in male Sprague Dawley rats. Results The NHT: CS: Sodium Tripolyphosphate (NHT: CS: TPP) ratio of 1:4:4 resulted in the lowest particle size of 120.36 ± 3.23 nm, the zeta potential of 36.06 ± 1.70 mV, the encapsulation efficiency of 96.16 ± 0.76%, and the loading capacity of 29.26 ± 1.09%. The NPs showed sustained release activity. The NHT-loaded CSNPs were stable for 90 days, with fibroblast and Calu-3 cell viability > 50%. In vivo studies revealed a lower area under the curve (AUC) and longer half-life (T½) compared to NHT, indicating safety and sustained release. Conclusion In conclusion, the optimized formulation exhibited sustained-release properties with potential use in future smoking cessation research.